Health-care workers received the first doses of the COVID-19 vaccine in December 2020.
GSK bullish on RSV vaccine battle against Pfizer, ships first Arexvy dose
GSK is bullish about the market prospects for its RSV vaccine Arexvy in older adults. The Big Pharma has already shipped its first doses to